CIK 0001427570
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Vyome Holdings, Inc
Sign in to watch- Ticker
- HIND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-429-6680
- Business address
- 1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
- Former names
- ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 1 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-23 | DITTAMORE RAYMOND V Director | Grant or award | +27,472 | $1.82 | $50K | 27,472 |
| 2018-08-23 | MOATAZEDI DAVID Director | Grant or award | −5,494 | $1.82 | $10K | 5,494 |
| 2018-08-23 | MONDORE ROBERT H JR VP of Operations | Grant or award | +13,736 | $1.82 | $25K | 13,736 |
| 2018-08-23 | Kamdar Kim P. Director | Purchase | +54,945 | $1.82 | $100K | 68,345 |
| 2018-08-23 | DOMAIN PARTERS VII L P 10% owner | Purchase | +1,648,359 | $1.82 | $3.0M | 5,634,329 |
| 2018-08-23 | INTERWEST PARTNERS X LP 10% owner | Purchase | +1,098,901 | $1.82 | $2.0M | 3,552,239 |
| 2018-06-13 | MOATAZEDI DAVID Director | Grant or award · Stock Option (Right to Buy) | +81,774 | 81,774 | ||
| 2018-06-13 | Kamdar Kim P. Director | Grant or award · Stock Option (Right to Buy) | +81,774 | 81,774 | ||
| 2018-06-13 | Stevenson Sharon Director | Grant or award · Stock Option (Right to Buy) | +81,774 | 81,774 | ||
| 2018-06-13 | SHACKNAI JONAH Director | Grant or award · Stock Option (Right to Buy) | +81,774 | 81,774 | ||
| 2018-06-13 | HOWE LESLEY H Director | Grant or award · Stock Option (Right to Buy) | +81,774 | 81,774 | ||
| 2018-06-13 | Fisher Douglas Director | Grant or award · Stock Option (Right to Buy) | +81,774 | 81,774 | ||
| 2018-06-13 | DITTAMORE RAYMOND V Director | Grant or award · Stock Option (Right to Buy) | +81,774 | 81,774 | ||
| 2018-06-13 | MOATAZEDI DAVID Director | Grant or award · Stock Option (Right to Buy) | +81,774 | 81,774 | ||
| 2018-05-15 | Young Donald R VP of Quality Assurance | Grant or award | +20,377 | 20,377 | ||
| 2018-05-15 | Hussainy Nooshin VP of Finance | Grant or award | +21,875 | 21,875 | ||
| 2018-05-15 | Huang Kelly Chief Operating Officer | Grant or award | +65,000 | 65,000 | ||
| 2018-05-15 | VandenBerg Amy VP of Reg. and Clin. Affairs | Grant or award | +15,000 | 75,000 | ||
| 2018-05-15 | Drake Neil VP Research and Development | Grant or award | +17,938 | 17,938 | ||
| 2018-05-15 | Plovanic William J. Chief Financial Officer | Grant or award | +45,000 | 45,000 |
Page 11 of 17 · 322 trades